Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NE3107 for Sleep and Fatigue in Traumatic Brain Injury
NCT05970575Phase 2Terminated
- Sponsor
- Neurological Associates of West Los Angeles
- Start
- Dec 2023
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bezisterim in traumatic brain injury (TBI), sponsored by Neurological Associates of West Los Angeles. Started Dec 2023; status: terminated.
02
Drugs
bezisterim
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT05970575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05970575.